Previous results have indicated that juvenile hormone analogues (JHA) showed effects on the development of eggs and nymphal stages of triatomine Chagas' disease vectors, and biological activ ity on Trypanosoma cruzi Chagas, 1909 epimastigotes (Rodriguez et al., 1988 Rodriguez et al., 1989; Stoka et al., 1990; Rodriguez et al., 1991) . It has been also shown that the insect Triatoma infestans Klug, 1834, Chagas' disease vector, after treatment with JHA is less susceptible to gut infec tions with T. cruzi than normal non-treated insects (Perlawagora-Szumlewicz et al., 1975) .
Those results encouraged the search for more active compounds against T. cruzi, and we wish to inform the preparation of additional JHA and their in vitro lytic activities on the microorganism causing Chagas' disease. Besides, some of the new compounds were tested in in vivo experiments on infected mice.
Materials and methods

Assays
In vitro. Trypanosoma cruzi infected mice blood was used to test the action of different concentra-R eprint requests to Prof. E. G. tions of JHA. The incubations were performed in polystirene 96 well U-plates at 4 °C during 24 h. In all experiments 100 [.tl of blood containing dif ferent quantities of trypomastigotes per ml and 2 |il of ethanolic solution of JHA were used. Etha nol (2 |xl) was used as control.
In vivo. Male 60-day-old BALB/c mice received 5 daily doses of different JHA in ethanol by the oral route (90 |ig of JHA/mouse/day), 30 min after infection of mice with 500 blood trypomastigotes via i.p.
Juvenile hormone analogues. The assayed com pounds are shown in Fig. 1 . Their respective prep arations have been described in literature; 1: 4-phenoxyphenyl prop-2-en-l-yl ether (Rodriguez et al., 1991) ; 2: 4-phenoxyphenoxyethyl tetrahydropyranyl ether (Rodriguez et al., 1989) ; 3: 5-ethyl (3,7,ll-trimethyl-10 et al., 1985) .
Results
The results on the lysis of T. cruzi (trypomasti gotes) by different concentration of the JHA are shown in Table I while the results obtained in the in vivo experiments are summarized in Table II. 0939-5075/95/0700-0578 $ 06.00 © 1995 Verlag d er Z eitschrift für N aturforschung. All rights reserved.
ig. 1. Juvenile h orm one analogues assayed as inhibitors of Trypanosoma cruzi replication. Table I . Lysis of Trypanosom a cruzi blood trypom asti gotes by treatm en t w ith juvenile ho rm o n e analogues at 4 °C. 
Discussion
The general aim of this project is to control the development of Trypanosoma cruzi in insects as well as in mammals. Despite of the progresses made in chemotherapy, new compounds are needed because the trypanocidal drugs presently in use, Nifurtimox and Benzmidazole, cause con siderable side effects on patients. There is no ef fective treatment available for Chagas' disease in spite of the important progresses made in the study of the biochemistry of the microorganism re sponsable for the mentioned disease (Marr and Docampo, 1986; Morello, 1988; Gutteridge, 1985) .
Bearing in mind the different studies on the ac tion of host's hormones on parasites, and our pre liminary experiments in which we have observed that JHA produce an inhibition of growth of T. cruzi epimastigotes in vitro, we have hypothe sized the probable action of JHA in the different stages of T. cruzi. Moreover, and due to the risk that T. cruzi may be transmitted in blood bank for transfusions, it is very important to have new compounds to kill parasites in blood to be transfused. At present. Gentian Violet is in use for this purpose but it suffers of serious limitations concerning its safety (Gutteridge, 1985) . Accord ingly, several JHA were tested in in vitro experi ments performed on blood from mice infected with T. cruzi trypomastigotes. When parasites were expose to the synthetic products (see Table  I ) compounds 1 and 4 showed the higher lytic ef fect on mouse blood trypomastigotes. Compound 4 at 1000 ^imol/1 lysed 100% of trypomastigotes when incubated with 5X10"1 parasites/ml. In sim ilar conditions, the best lytic effect of compound 1 was 94%. The values determined for compounds 2 and 3 indicated that their lytic capacity, although similar between them, are inferior to those ob tained with 1 and 4. The respective values regis tered for these compounds indicated that they could be used for blood sterilization.
In experiments in vivo, JHA showed a moder ated degree of activity against the parasites. As seen in Table II , the best percentages of survival were observed in mice treated with compounds 1 and 2 (71 and 64% respectively) compared with control mice (36%). Unexpectedly, compound 4 did not present activity in these in vivo assays even G utteridge W. E. (1985) . when tested at twofold doses than those used for the other compounds. Although the differences were not statistically significant, parasitemia level of mice treated with 1 and 2 were lower than those from control mice.
